Joint Formulary & PAD

Morphine sulfate - Breathlessness in palliative care

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Immediate release tablets
  • Oral solution
  • Oro-dispersible
Associated Icons :
BNF SPC
CD
Restrictions / Comments :
 

Status 2

Green (see narrative)
Formulations :
  • Modified release capsules
  • Modified release tablets
Associated Icons :
BNF SPC
CD
Restrictions / Comments :
Important

Prescribe modified-release preparations by brand - refer to local guidelines for preferred brands. Zomorph capsules (12-hourly) can be opened for administration in patients unable to swallow the capsules.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Morphine sulfate
Indication :
Breathlessness in palliative care
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Morphine sulfate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Breathlessness in palliative care.

  • No records returned.

Committee Recommendations (0)

  • No records returned.